Insider Transactions Reported by 17 Insiders of Rhythm Pharmaceuticals, Inc.

Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
Boston, MA

Insiders trading volume in the past year

Rhythm Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Meeker President and CEO, Director $16.9M -$3.66M -17.8% Jun 3, 2025
Hunter C. Smith Chief Financial Officer $12.4M -$7.87M -38.9% Aug 12, 2025
Yann Mazabraud EVP, Head of International $2.92M -$5.38M -64.9% Apr 29, 2025
Pamela J. Cramer Chief Human Resources Officer $2.88M -$6.65M -69.8% Dec 11, 2025
Alastair Garfield Chief Scientific Officer $1.73M -$85.5K -4.72% Jul 1, 2025
Joseph Shulman Chief Technical Officer $1.69M -$6.45M -79.2% Oct 30, 2025
Jennifer Kayden Lee EVP, Head of North America $1.28M -$866K -40.4% Feb 14, 2025
Edward T. Mathers Director $769K Jun 24, 2025
Linda Shapiro Manning Chief Medical Officer $563K Feb 9, 2022
Jennifer L. Good Director $421K Jun 24, 2025
Camille L. Bedrosian Director $421K Jun 24, 2025
Stuart A. Arbuckle Director $421K Jun 24, 2025
Lynn A. Tetrault Director $421K Jun 24, 2025
D. W. J. Mcgirr Director $421K -$4.27M -91% Jun 24, 2025
Christophe Jean Director $421K Jun 24, 2025
William T. Roberts Chief Accounting Officer $279K Mar 29, 2023
Christopher Paul German Corporate Controller & CAO $208K -$645K -75.6% Aug 12, 2025

Recent Insider Transactions by Companies or Individuals for Rhythm Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.